红鹰彩票软件,光大彩票登录官方平台,乐鱼官方网站在线登录网页,澳门网上真人注册,凤凰彩票手机,凤凰彩票注册,大小单双彩票app平台网站

On March 21, the Yttrium-90 [90Y] Resin Microsphere Clinical Technology Launch Conference was held at Xiamen Humanity Hospital. The Yttrium-90 technology officially landed in Xiamen, adding a "nuclear weapon" to the treatment of liver cancer in the southern Fujian region.
In recent years, Yttrium-90 [90Y] microsphere injections have been widely used in nearly 50 countries and regions worldwide. Xiamen Humanity Hospital took the lead in applying for the Yttrium-90 project within the province and officially obtained approval on March 11 this year, becoming the first medical institution in Southern Fujian to officially launch Yttrium-90 technology. So far, more than 200 liver tumor patients in China have received Yttrium-90 [90Y] treatment, and its efficacy has been recognized by domestic liver tumor experts.